Lice Treatment Market Size To Expand at a Notable CAGR Of 6.5% During 2018-2023 :

Pune, India, April 2018 /MRFR Press Release/- Market Research Future published a half-cooked research report on the Global Lice Treatment Market.

Market Highlights:

The Global Lice Treatment Market is expected to grow at an approximate CAGR of 6.5% during forecast period, 2018–2023.Lice are parasites striving on human blood. They can be found on head or pubic areas. From the past few years, rising prevalence of head lice provided developmental backgrounds for the market. Factors such as growing children population and increasing disposable income are driving the market. However, lack of awareness followed by low per capita healthcare expenditure in the developing and low-income countries is estimated to restraint the market growth, during the forecast period.


The global lice treatment market is segmented based on type, treatment, end user, and region Based on type, the market is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. On the basis of treatment, the market is divided into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is bifurcated into permethrin, pyrethrin, and others.  The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By distribution channel, the market is segmented into hospitals & clinics, retail pharmacies, and online platform. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.

Regional Analysis:

The Americas leads the global lice treatment market. This can be attributed due to growing child population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth. In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global lice treatment market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.

Browse Complete Report @

Key Players:

Some of the key players in the global lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others


Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: .